ABSI
Price
$3.04
Change
-$0.29 (-8.71%)
Updated
Dec 18 closing price
90 days until earnings call
INZY
Price
$2.76
Change
-$0.18 (-6.12%)
Updated
Dec 18 closing price
91 days until earnings call
Ad is loading...

ABSI vs INZY

Header iconABSI vs INZY Comparison
Open Charts ABSI vs INZYBanner chart's image
Absci
Price$3.04
Change-$0.29 (-8.71%)
Volume$3.4M
CapitalizationN/A
Inozyme Pharma
Price$2.76
Change-$0.18 (-6.12%)
Volume$587.91K
CapitalizationN/A
ABSI vs INZY Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. INZY commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and INZY is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (ABSI: $3.04 vs. INZY: $2.76)
Brand notoriety: ABSI and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 202% vs. INZY: 105%
Market capitalization -- ABSI: $382.47M vs. INZY: $188.87M
ABSI [@Biotechnology] is valued at $382.47M. INZY’s [@Biotechnology] market capitalization is $188.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 0 green, 5 red.
According to our system of comparison, ABSI is a better buy in the long-term than INZY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 4 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • ABSI’s TA Score: 4 bullish, 6 bearish.
  • INZY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, INZY is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -30.59% price change this week, while INZY (@Biotechnology) price change was -6.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.34%. For the same industry, the average monthly price growth was -2.44%, and the average quarterly price growth was +0.79%.

Reported Earning Dates

ABSI is expected to report earnings on Mar 19, 2025.

INZY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-4.34% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($382M) has a higher market cap than INZY($189M). ABSI YTD gains are higher at: -27.619 vs. INZY (-35.211). ABSI has higher annual earnings (EBITDA): -83.27M vs. INZY (-90.3M). INZY (132M) and ABSI (127M) have equal amount of cash in the bank . ABSI has less debt than INZY: ABSI (12M) vs INZY (46.8M). ABSI has higher revenues than INZY: ABSI (4.21M) vs INZY (0).
ABSIINZYABSI / INZY
Capitalization382M189M202%
EBITDA-83.27M-90.3M92%
Gain YTD-27.619-35.21178%
P/E RatioN/AN/A-
Revenue4.21M0-
Total Cash127M132M96%
Total Debt12M46.8M26%
TECHNICAL ANALYSIS
Technical Analysis
ABSIINZY
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 7 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIIGX23.86N/A
N/A
Gabelli International Growth I
ASRIX7.81-0.21
-2.62%
Invesco Global Real Estate Income R5
TGVYX54.22-1.83
-3.26%
Touchstone Growth Opportunities Y
TILHX28.86-1.04
-3.48%
Nuveen Large Cap Growth I
JDSRX21.85-0.91
-4.00%
Janus Henderson Small Cap Value R

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with BEAM. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-8.71%
BEAM - ABSI
48%
Loosely correlated
-7.45%
CRSP - ABSI
47%
Loosely correlated
-8.00%
PRME - ABSI
46%
Loosely correlated
-9.28%
INZY - ABSI
45%
Loosely correlated
-6.12%
RXRX - ABSI
45%
Loosely correlated
-12.71%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-6.12%
BEAM - INZY
57%
Loosely correlated
-7.45%
NAUT - INZY
53%
Loosely correlated
-8.59%
ABOS - INZY
49%
Loosely correlated
-8.67%
DNLI - INZY
49%
Loosely correlated
-7.71%
RXRX - INZY
48%
Loosely correlated
-12.71%
More